Niva Bupa Health Insurance Company Ltd, a standalone health insurer, reported a remarkable 67% increase in net profit, reaching ₹345 crore for the March quarter of FY26, compared to ₹206 crore during the same period last year. The company's total income also saw significant growth, rising to ₹2,078 crore from ₹1,565 crore year-on-year. Gross written premiums surged to ₹2,880 crore, up from ₹2,079 crore in the previous year, indicating strong business performance. However, the solvency ratio declined to 2.49 as of March 31, 2026, down from 3.03 at the end of the previous fiscal year, raising some concerns about financial stability. The company's focus on customer service is evident in its improved claim settlement ratio of 94.4%, which is an increase of 205 basis points over the previous year. Additionally, the board has approved the promotion of Ankur Kharbanda to the position of executive director and deputy chief executive officer, effective May 8. Niva Bupa's managing director and CEO, Krishnan Ramachandran, highlighted the company's strengthened position in the retail health segment, with market share improving to 10.1% at the end of FY26, reflecting the trust customers place in the company.